Acute migraine headache. Other headache syndromes
Conditions
Interventions
Intervention 1: Intervention group: First, they will receive 2 cc (equivalent to 10 mg) of metoclopramide intraserum. Then, one gram of intravenous acetaminophen (equivalent to 7 cc) along with 100 cc
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: The presence of migraine criteria according to the classification of the International Headache Society Headache pattern consistent with migraine and previous attack
Exclusion criteria
Exclusion criteria: History of allergy to metoclopramide or acetaminophen History of liver, renal and heart failure, malignancy Pregnancy and breastfeeding History of gastrointestinal obstruction or gastrointestinal bleeding or clinical suspicion of either Trauma, seizure or abnormal neurological examination Smoking or drug use High systolic and diastolic blood pressure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Headache Severity. Timepoint: Before treatment, 15 minutes and 30 minutes after treatment. Method of measurement: Visual Analogue Scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Need for additional analgesic. Timepoint: 60 minutes after treatment onset. Method of measurement: Extracting on patient's medical record.;Complications, nausea, vomiting, blurred vision, drowsiness and restlessness. Timepoint: Within an hour after treatment. Method of measurement: by asking the patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbbas Moradi
Hamedan University of Medical Sciences
Outcome results
None listed